S.A. Carson

No ORCID on file · 6 papers in corpus · active 2001-2005

Study types

  • article 6

Condition tags

  • endometriosis 6
article 2005
Depot Medroxyprogesterone Acetate Subcutaneous Injection 104 mg/0.65 mL (DMPA-SC 104) is Associated With Fewer Hypoestrogenic Symptoms in Patients With Endometriosis Than Leuprolide Acetate
·doi:10.1016/j.fertnstert.2005.07.479
article 2005
DMPA-SC 104 provides similar duration of posttreatment relief from the symptoms of endometriosis as compared with leuprolide acetate
·doi:10.1016/j.contraception.2005.06.008
article 2004
New low dose depot medroxyprogesterone acetate subcutaneous injection is equivalent to leuprolide acetate for endometriosis-associated pain
·doi:10.1016/j.fertnstert.2004.07.182
article 2002
Hacia el origen molecular de la endometriosis
article 2002
NAT2 and GSTM1 DNA polymorphisms: increased GSTM1 (active) genotypes in endometriosis
·doi:10.1016/s0015-0282(01)03059-x
article 2001
Evaluation of chromosome 17 aneuploidy and p53 loss in endometriosis by fluorescence in situ hybridization (FISH).
·doi:10.1016/s0015-0282(01)02150-1